For 10 years we have been working large pharmaceutical and cell and gene therapy companies to develop assays and data using our methodologies and technologies. We are focused on the discovery and detection of complex genetic changes; detecting structural variations quicker than that of our competitors. Our patented technology, known as directional Genomic Hybridization™ (dGH) combines bioinformatics driven design of unique single-stranded synthetic oligonucleotide probes with strand-specific hybridization strategies, with lower limits of detection in 2kb range. Ours is the only genomics approach capable of detecting DNA sequence, location and orientation in one single test.
We provide a wide range of DNA probe products; chromosome paints and probes; assay services and high-quality cell culture services. Providing validated QC of cell lines, and customizable cell services. Our guarantee is to provide you with customized assay development beyond that of our competitors and competitive pricing to help save you on your hard earned money.